Atlas market file · Equity · United States
National Vision Holdings, Inc.EYE
- Last close
- 22.47
- Change
- -2.43%
- 96-bar range
- 14.75 – 28.8
- As of
- 6 Aug 2026
National Vision Holdings, Inc. is an ophthalmic goods issuer listed as EYE on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
EYE
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+113.80% over the window).
Source rail: Yahoo Finance chart API (EYE). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for EYE. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
EYE public profile
Ophthalmic goods issuer. National Vision Holdings, Inc. is connected to current market context, cited company sources and its retained research file.
National Vision Holdings, Inc. trades as EYE on NASDAQ. National Vision Holdings, Inc. (EYE) has a latest verified close of 22.47, down 2.43%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files EYE under USA Stocks for browsing.
What changed for National Vision Holdings, Inc. today
National Vision Holdings (EYE) posted $543.9M in revenue for the quarter ended April 2026, driven by its retail optical chain spanning over 1,200 stores. However, the company’s inventory surged by $19.6M, raising questions about demand forecasting amid a competitive environment of discount vision providers.
EYE’s core business revolves around selling glasses, contact lenses, and eye exams, with 81.5M diluted shares outstanding. Its recent 8-K filing confirmed guidance ahead of investor meetings, though the methodology for calculating ‘adjusted comparable store sales growth’-comparing mismatched weeks-has drawn skepticism from analysts.
Financials show net income of $31.2M and operating cash flow of $61.7M, but capital expenditures ($17.6M) and inventory growth suggest near-term pressures. The company’s cash reserves ($67.9M) remain modest relative to its $2.02B asset base, limiting flexibility for large acquisitions or buybacks.
The stock’s performance hinges on execution in a sector where price competition and consumer discretionary spending volatility are persistent risks. EYE’s ability to convert inventory buildup into sales without deep discounts will be a critical watchpoint.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
EYE technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on EYE
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep EYE research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
EYE FAQ
What is National Vision Holdings, Inc. (EYE)?National Vision Holdings, Inc. (EYE) has a latest verified close of 22.47, down 2.43%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
National Vision Holdings, Inc. (EYE) has a latest verified close of 22.47, down 2.43%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for EYE?National Vision Holdings, Inc. (EYE) has a latest verified close of 22.47, down 2.43%, dated 6 Aug 2026. It brings the latest available chart, company context, cited...
National Vision Holdings, Inc. (EYE) has a latest verified close of 22.47, down 2.43%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files EYE under USA Stocks for browsing.
How often is the EYE page updated?The EYE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The EYE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for EYE?The EYE file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:EYE. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The EYE file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:EYE. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on EYE?Yes. The workstation can open EYE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open EYE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this EYE page investment advice?No. The EYE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The EYE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →